Jozsef Palatka, M.D.

Jozsef Palatka serves as Senior Vice President and Global Therapeutic Head for Oncology at Parexel, based in Budapest, Hungary. He specializes in solid tumors, emerging treatment modalities such as antibody drug conjugates (ADCs), and the design of innovative clinical trial strategies that optimize speed, feasibility, and regulatory alignment.

Work Experience

Jozsef is an oncology drug development leader with more than 25 years of experience across the pharmaceutical and CRO sectors. He has guided high performing global teams through all phases of clinical development and has served as a strategic partner to biopharma sponsors worldwide. Throughout his career, he has led oncology programs spanning a broad range of solid tumors and cutting edge modalities, providing expertise in development strategy, clinical trial design, and operational execution.

His work focuses on accelerating oncology drug development while upholding the highest standards of scientific rigor, quality, and compliance. Jozsef has deep expertise in developing and implementing novel trial solutions and delivery models that balance speed with operational practicality and regulatory expectations - ultimately helping bring new therapies to patients with cancer more efficiently.

Education

Jozsef holds an M.D. from Semmelweis University of Medicine, Budapest, Hungary, and a degree in Biomedical Engineering from Technical University, Budapest, Hungary. He is Board Certified in Pharmaceutical Medicine from the University of Basel, Switzerland.